Future work, given ongoing availability of longitudinal tau‐PET data from ADNI, could use the same cluster mapping to investigate AD progression, validate the re‐labelling, and the hypothesis that the NRF cluster is a high‐risk group. Here, MAPT is linked to Alzheimer disease.